Ildong seeks sales boost of 3 flagship products

Ildong Pham unveiled its plan to beep up the marketing activities of its three leading products, including Samion and Curan , to achieve a 90 billion-won in combined sales.

Samion (nicergolin), cerebrovascular medicine, has fared well thanks to the company’s intensive marketing campaigns. Samion has garnered more than 10 billion won in revenue, while most of nicergolin drug makers discontinu...